TEMPE, Ariz., July 23, 2015 (GLOBE NEWSWIRE) -- Capstone Therapeutics Corp. ( OTCQB:CAPS ) ("the Company") and its joint venture affiliate, LipimetiX Development, Inc. ("JV"), announced today the conversion of a provisional U.S. Patent application ... BioSpace, 5 days ago
Capstone Therapeutics (CAPS) Announces Patent Application For Novel, More Potent Chimeric Apo E Mimetic Peptides 7/23/2015 - ClinicSpace, 5 days ago
Capstone Therapeutics Corp (CAPS: OTCQB) | Capstone Therapeutics Announces Settlement of Qui Tam Lawsuit - OTC Markets, 1 month ago
The reelin protein plays a starring role in neural development, and new findings suggest the neuromodulator does an important job in older animals, too. Researchers led by Joachim Herz at the University of Texas Southwestern Medical Center in Dallas ...Alzheimer Research Forum, 1 week ago
Abstract Laying performance is an important economical trait of goose production. As laying performance is of low heritability, it is of significance to develop a marker-assisted selection (MAS) strategy for this trait. Definition of sequence ...Plosone.org, 1 week ago
Summary and Comment | July 2, 2015 Karol E. Watson, MD, PhD, FACC reviewing Hovingh GK et al. Lancet 2015 Jun 2. Ray KK and Vallejo-Vaz AJ. Lancet 2015 Jun 2. Karol E. Watson, MD, PhD, FACC A phase 2 study helps ...New England Journal of Medicine, 1 week ago
REGENERON PHARMACEUTICALS : Findings on Lipid Research Reported by Investigators at Regeneron Pharmaceuticals Inc. (Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride...
Findings on Lipid Research Reported by Investigators at Regeneron Pharmaceuticals Inc. (Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion) By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Lipid ...4 Traders, 1 week ago
by Juan Martínez-Oliván, Hugo Fraga, Xabier Arias-Moreno, Salvador Ventura, Javier Sancho The LDL receptor internalizes circulating LDL and VLDL particles for degradation. Its extracellular binding domain contains ten (seven LA and three EGF) ...Plosone.org, 2 weeks ago
Up-Regulation Mttp and Apob Gene Expression in Rat Liver is Related to Post-Lipectomy Hypertriglyceridemia
American Academy of Cosmetic Surgery (AACS): 2006 Guidelines for Liposuction Surgery. In: 2006: A joint Ad Hoc Committee of the American Society of Lipo-Suction Surgery (ASLSS) and the American Academy of Cosmetic Surgery 2006.Cellular Physiology and Biochemistry, 2 weeks ago
Jul. 10, 2015 8:19 AM ET | About: Amgen Inc. (AMGN), Includes: CAPS, CCXI, IPSEF, JNJ, LLY, MRK, SNY by: Kanak Kanti De Summary The FDA advisory committee on Eli Lilly's Necitumumab met yesterday, but hasn't voted yet. Amgen is closer to ...Seeking Alpha, 2 weeks ago
Disclosed is a novel NASH marker for use in a method for detecting NASH or evaluating the severity of NASH, which utilizes at least one factor selected from the group consisting of an IL-1 receptor antagonist, sCD40, HMGB1, sPLA2 group IIA and an ...PharmCast, 2 weeks ago
Akcea Therapeutics, a developer of RNA-targeted antisense therapeutics, has received orphan drug designation from the FDA for volanesorsen for the treatment of patients with familial chylomicronemia syndrome, or FCS. In a Phase II study published in ...Individual.com, 2 weeks ago Akcea gets FDA orphan drug status for volanesorsen to treat familial chylomicronemia syndrome Pharmaceutical Business Review, 3 weeks ago US FDA grants orphan drug status to Akcea Therapeutics' volanesorsen to treat familial chylomicronemia syndrome PharmaBiz, 3 weeks ago Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen News-Medical.Net, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!